北陆药业(300016.SZ)拟以简易程序定增募资不超3亿元

Core Viewpoint - Beilu Pharmaceutical (300016.SZ) plans to issue shares to specific targets through a simplified procedure, aiming to raise no more than 300 million yuan for various projects and working capital [1] Group 1: Share Issuance Details - The company intends to issue shares to no more than 35 specific targets [1] - The issuance price will not be lower than 80% of the average trading price of the company's shares over the 20 trading days prior to the pricing benchmark [1] - The total number of shares issued will be determined by the total amount of funds raised divided by the issuance price, not exceeding 30% of the company's total share capital before the issuance [1] Group 2: Fund Utilization - The total amount raised from the share issuance will not exceed 300 million yuan, including the principal [1] - After deducting related issuance costs, the net proceeds will be fully invested in the construction of the Luzhibao pharmaceutical production workshop and intelligent comprehensive warehouse project [1] - Additional investments will be made in the technical transformation project for a new 100-ton iodinated methylpyrrolidone and 50-ton iodinated butanol raw material production line, as well as to supplement working capital [1]